Cargando…
Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis
Several lines of evidence have supported the role of immunological mechanisms in the pathogenesis of multiple sclerosis (MS) and new immunomodulatory strategies for its treatment, e.g. subcutaneous application of interferon (IFN)-β, have emerged. We investigated the ability of peripheral blood monon...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science B.V.
1997
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127026/ https://www.ncbi.nlm.nih.gov/pubmed/9168171 http://dx.doi.org/10.1016/S0022-510X(97)05383-5 |